Pennant Investors »

Nurix Therapeutics shares owned by Pennant Investors

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.2M 57k 20.87
2024-03-31 $835k 57k 14.70

More positions owned by Pennant Investors

Echostar Corp Cl A (SATS)
Antero Res (AR)
Perimeter Solutions Sa Common Stock (PRM)
Micron Technology (MU)
Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Vertiv Holdings Com Cl A (VRT)
Ge Vernova (GEV)
Valmont Industries (VMI)
Core Scientific (CORZ)
Iris Energy Ordinary Shares (IREN)
Asml Holding N V N Y Registry Shs (ASML)
Grab Holdings *w Exp 99/99/999 (GRABW)

View all positions for Pennant Investors

Top funds holding Nurix Therapeutics

BlackRock
Redmile Group
Vanguard Group
Baker Bros. Advisors
Deep Track Capital
Wellington Management Company
T. Rowe Price Associates
T. Rowe Price Investment Management
State Street Corporation
ARK Investment Management
Pictet Asset Management Holding SA
Commodore Capital
Citadel Advisors
Geode Capital Management
Driehaus Capital Management

View all funds holding Nurix Therapeutics